DK626089D0 - Middel til kontrolleret frigivelse af polypeptider - Google Patents

Middel til kontrolleret frigivelse af polypeptider

Info

Publication number
DK626089D0
DK626089D0 DK626089A DK626089A DK626089D0 DK 626089 D0 DK626089 D0 DK 626089D0 DK 626089 A DK626089 A DK 626089A DK 626089 A DK626089 A DK 626089A DK 626089 D0 DK626089 D0 DK 626089D0
Authority
DK
Denmark
Prior art keywords
polypeptides
agent
controlled release
release
controlled
Prior art date
Application number
DK626089A
Other languages
English (en)
Other versions
DK626089A (da
Inventor
Michael Joseph Azain
Thomas Richard Kasser
Milton Jerome Sabacky
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co filed Critical Monsanto Co
Publication of DK626089D0 publication Critical patent/DK626089D0/da
Publication of DK626089A publication Critical patent/DK626089A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DK626089A 1988-12-13 1989-12-12 Middel til kontrolleret frigivelse af polypeptider DK626089A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28368588A 1988-12-13 1988-12-13
US42168189A 1989-10-18 1989-10-18

Publications (2)

Publication Number Publication Date
DK626089D0 true DK626089D0 (da) 1989-12-12
DK626089A DK626089A (da) 1990-06-14

Family

ID=26962178

Family Applications (1)

Application Number Title Priority Date Filing Date
DK626089A DK626089A (da) 1988-12-13 1989-12-12 Middel til kontrolleret frigivelse af polypeptider

Country Status (13)

Country Link
EP (1) EP0374120A3 (da)
JP (1) JPH02204418A (da)
KR (1) KR920005660B1 (da)
CN (1) CN1043631A (da)
AU (1) AU4617689A (da)
BR (1) BR8906435A (da)
CA (1) CA2005226A1 (da)
CZ (1) CZ702889A3 (da)
DK (1) DK626089A (da)
HU (1) HUT52395A (da)
IL (1) IL92662A0 (da)
NZ (1) NZ231730A (da)
PT (1) PT92548A (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981485A (en) 1997-07-14 1999-11-09 Genentech, Inc. Human growth hormone aqueous formulation
IE920773A1 (en) * 1991-03-12 1992-09-23 Alza Corp Space and stability-efficient delivery device
US5861166A (en) * 1991-03-12 1999-01-19 Alza Corporation Delivery device providing beneficial agent stability
US5849704A (en) * 1991-12-20 1998-12-15 Novo Nordisk A/S Pharmaceutical formulation
DE69232847T2 (de) * 1991-12-20 2003-09-11 Novo Nordisk A/S, Bagsvaerd Stabilisierte pharmazeutische formulierung, die wachstumshormon und histidin enthält
DK204791D0 (da) * 1991-12-20 1991-12-20 Novo Nordisk As Hidtil ukendt farmaceutisk praeparat
DK136492D0 (da) * 1992-11-10 1992-11-10 Novo Nordisk As A pharmaceutical formulation
US6022858A (en) * 1991-12-20 2000-02-08 Novo Nordisk A/S Pharmaceutical formulation of human-growth hormone pretreated with zinc salt
US5849700A (en) * 1991-12-20 1998-12-15 Novo Nordisk A/S Pharmaceutical formulation
US5198422A (en) * 1992-06-11 1993-03-30 Smithkline Beecham Corporation Stabilized somatotropin for parenteral administration
EP0916719A3 (en) * 1992-11-03 1999-07-14 The Procter & Gamble Company Cleaning with short-chain surfactants
ZA949350B (en) 1994-01-25 1996-05-24 Upjohn Co Aqueous prolonged release formulation
US5595752A (en) * 1994-07-01 1997-01-21 Monsanto Company Increasing dressing percentage and carcass weight in finishing beef cattle
US5672357A (en) * 1994-07-01 1997-09-30 Monsanto Company Method and device for implantation of large diameter objects in bovines
US5631225A (en) * 1994-10-13 1997-05-20 Novo Nordisk A/S Pharmaceutical formulation
US5547696A (en) * 1994-10-13 1996-08-20 Novo Nordisk A/S Pharmaceutical formulation
US5654278A (en) * 1994-10-13 1997-08-05 Novo Nordisk A/S Composition and method comprising growth hormone and leucine
US5705482A (en) * 1995-01-13 1998-01-06 Novo Nordisk A/S Pharmaceutical formulation
US5552385A (en) * 1995-06-05 1996-09-03 Novo Nordisk A/S Pharmaceutical formulation
US5904935A (en) * 1995-06-07 1999-05-18 Alza Corporation Peptide/protein suspending formulations
AUPN801296A0 (en) * 1996-02-12 1996-03-07 Csl Limited Stabilised growth hormone formulation and method of preparation thereof
US20070179096A1 (en) 1996-04-24 2007-08-02 Novo Nordisk A/S Pharmaceutical Formulation
ZA9711731B (en) * 1996-12-31 1998-07-01 Monsanto Co Aqueous glycerol formulations of somatotropin
EP0880969A1 (en) * 1997-05-28 1998-12-02 Applied Research Systems ARS Holdings N.V. Pharmaceutical compositions of peptides having low solubility in physiological medium
JP2002533378A (ja) * 1998-12-23 2002-10-08 アムジエン・インコーポレーテツド タンパク質の徐放用ポリオール／油懸濁液
US6245740B1 (en) 1998-12-23 2001-06-12 Amgen Inc. Polyol:oil suspensions for the sustained release of proteins
AU2001238540A1 (en) 2000-02-24 2001-09-03 Monsanto Technology Llc Non-aqueous injectable formulations for extended release of somatotropin
AU2001271491A1 (en) 2000-06-26 2002-01-08 Monsanto Technology Llc Non-aqueous surfactant-containing formulations for extended release of somatotropin
US6664234B1 (en) 2000-06-30 2003-12-16 Monsanto Technology Llc Non-aqueous injectable formulation preparation with pH adjusted for extended release of somatotropin
US20030089447A1 (en) * 2001-11-06 2003-05-15 Kenneth Molee Soft absorbent garment made with discretely coated elastic elements, and system and method for making a soft absorbent garment
ITMI20021684A1 (it) * 2002-07-29 2004-01-29 Therapicon Srl Composizione farmaceutica di peptide nasale

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3987790A (en) * 1975-10-01 1976-10-26 Alza Corporation Osmotically driven fluid dispenser
JPS61500439A (ja) * 1983-11-21 1986-03-13 リ−ジエンツ　オヴ　ザ　ユニヴア−シテイ−　オヴ　ミネソタ 慢性的非経口ホルモン投与用緩衝化ポリオ−ル−ホルモン混合物
US4917685A (en) * 1986-05-16 1990-04-17 International Minerals & Chem. Corp. Delivery device for the administration of stabilized growth promoting hormones
US4855141A (en) * 1988-03-25 1989-08-08 Alza Corporation Device comprising means for protecting and dispensing fluid sensitive medicament

Also Published As

Publication number Publication date
CN1043631A (zh) 1990-07-11
KR910007542A (ko) 1991-05-30
CZ702889A3 (en) 1995-01-18
EP0374120A3 (en) 1991-07-31
DK626089A (da) 1990-06-14
KR920005660B1 (ko) 1992-07-13
PT92548A (pt) 1990-06-29
HUT52395A (en) 1990-07-28
BR8906435A (pt) 1990-08-28
HU896513D0 (en) 1990-02-28
CA2005226A1 (en) 1990-06-13
IL92662A0 (en) 1990-08-31
NZ231730A (en) 1991-10-25
EP0374120A2 (en) 1990-06-20
JPH02204418A (ja) 1990-08-14
AU4617689A (en) 1990-06-21

Similar Documents

Publication Publication Date Title
DK626089D0 (da) Middel til kontrolleret frigivelse af polypeptider
DK89091D0 (da) Fremgangsmaade til fremstilling af vitamin-d-forbindelser
DK295889A (da) Fremgangsmaade til sammenklaebning af materialelag
DK230789D0 (da) Fremgangsmaade til fremstilling af cytidinderivater
DK121591A (da) Fremgangsmaade til fremstilling af gelatinefolier
DK453789A (da) Fremgangsmaade til paavirkning af azopigmenters triboelektriske effekt
DK461589A (da) Uv-haerdelig materialer til fremstilling af trykte kredsloeb
DK468888D0 (da) Fremgangsmaade til fresmtilling af keramiske pulvere
DK250689A (da) Fremgangsmaade til fremstilling af napthalenderivater
DK349689D0 (da) Fremgangsmaade til fremstilling af keramiske formdele
DK30489D0 (da) Fremgangsmaade til fremstilling af pyranderivater
DK200489D0 (da) Fremgangsmaade til fremstilling af polypeptider
DK315789A (da) Fremgangsmaade til fremstilling af halogenerede sulfoner
DK601489A (da) Fremgangsmaade til fremstilling af alkansulfonamider
DK589089D0 (da) Anvendelse af benzomorphaner til cytoprotektion
DK143889A (da) Fremgangsmaade til fremstilling af naphthalenderivater
DK356789D0 (da) Fremgangsmaade til hydrogenolyse af halogenerede aromatiske forbindelser
DK19889D0 (da) Fremgangsmaade til fremstilling af polypeptider
DK293589D0 (da) Fremgangsmaade til fremstiling af lactolderivater
DK184789A (da) Fremgangsmaade til fremstilling af naphthalenderivater
DK599689D0 (da) Fremgangsmaade til fremstilling af naphthalenderivater
DK162789D0 (da) Fremgangsmaade til fremstilling af alkalimetalphenylpyruvat
DK127589A (da) Fremgangsmaade til fremstilling af phenolskumstoffer
DK629089D0 (da) Fremgangsmaade til fremstilling af arylacetotrifluorethoxyphenylketoner
DK322688A (da) Profylaktisk middel til kontrol af koenssydomme

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment